Cite
HARVARD Citation
Ribera, E. et al. (n.d.). Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. HIV medicine. 14 (6), pp. 327-336. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ribera, E. et al. (n.d.). Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. HIV medicine. 14 (6), pp. 327-336. [Online].